FFA
RGNX icon

Farther Finance Advisors’s Regenxbio RGNX Stock Holding History

Farther Finance Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.68K Buy
754
+606
+409% +$6.15K ﹤0.01% 4938
2026
Q2 		$1.77K Sell
148
-220
-60% -$1.83K ﹤0.01% 5201
2026
Q1 		$3.18K Sell
368
-51
-12% -$536 ﹤0.01% 4712
2025
Q4 		$6.03K Buy
419
+399
+1,995% +$4.97K ﹤0.01% 4200
2025
Q3 		$193 Buy
+20
New +$177 ﹤0.01% 4724
2025
Q2 		– Sell
-2,382
Closed -$16.1K – 4632
2025
Q1 		$16.1K Buy
+2,382
New +$17.7K ﹤0.01% 2494
2024
Q4 		– Sell
-33
Closed -$346 – 4124
2024
Q3 		$346 Hold
33
– – ﹤0.01% 3515
2024
Q2 		$365 Hold
33
– – ﹤0.01% 3347
2024
Q1 		$710 Buy
33
+22
+200% +$391 ﹤0.01% 2906
2023
Q4 		$197 Buy
+11
New +$194 ﹤0.01% 3228

Other funds holding RGNX

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Farther Finance Advisors's RGNX Position: Q3 2026 in Review

Farther Finance Advisors increased its Regenxbio (RGNX) stake by 409% in Q3 2026, buying an estimated $6.15K and bringing the position to 754 shares worth $5.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4938.

Farther Finance Advisors first reported a position in RGNX in Q4 2023 and has held it in 10 quarters since. The position peaked at $16.1K in Q1 2025. 4 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Farther Finance Advisors held 754 shares of Regenxbio worth $5.68K as of Q3 2026.
  • Farther Finance Advisors bought 606 Regenxbio shares in Q3 2026, an estimated $6.15K.
  • Regenxbio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4938 holding.
  • Farther Finance Advisors first reported a position in Regenxbio in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Regenxbio position peaked at $16.1K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.